Kinnos

About Kinnos

Kinnos is a company focused on revolutionizing disinfection solutions to protect patients and communities worldwide. Their mission is to improve cleaning techniques and ensure more effective and efficient surface disinfection in healthcare environments without disrupting workflow.

Products & Services

Highlight(r):A technology that adds color to disinfectants to visualize surface coverage, ensuring complete cleaning. It is compatible with common disinfectant wipes, standardizes performance, and provides visible confirmation of effective cleaning techniques.

Specialties

Disinfection Technology Infection Prevention Surface Cleaning Solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Financing T: - FT: Financing	A: 15000000 MR: - FA: $15 million FAN: 15000000	D: 2023-05-02 FD: 2023-05-02	3 investors

Financing Latest

2023-05-02

$15.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jason Kang

Chief Executive Officer & Co-Founder

M

Melissa Comunale

Head of Commercial

Q

Quinton Farrar

Chief Operating Officer

K

Katherine Jin

Senior Technology Advisor & Co-Founder

S

Son Pham

Chief Financial Officer

S

Suzanne Thompson

Head of R&D

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

Kinnos Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised